Targeted hepatocellular carcinoma therapy: transferrin modified, self-assembled polymeric nanomedicine for co-delivery of cisplatin and doxorubicin

References

• Greco F, Vicent MJ. Combination therapy: opportunities and challenges for polymer–drug conjugates as anticancer nanomedicines. Adv Drug Deliv Rev 2009;61:1203–13.
   PubMed Web of Science ®Google Scholar
• Gomaa AI, Waked I. Recent advances in multidisciplinary management of hepatocellular carcinoma. World J Hepatol 2015;7:673–87.
   PubMed Web of Science ®Google Scholar
• Kwak MS, Yu SJ, Yoon JH, et al. Synergistic anti-tumor efficacy of doxorubicin and flavopiridol in an in vivo hepatocellular carcinoma model. J Cancer Res Clin Oncol 2015;141:2037–45.
   PubMed Web of Science ®Google Scholar
• Abdel-Rahman O, Fouad M. Second line systemic therapy options for advanced hepatocellular carcinoma; a systematic review. Expert Rev Anticancer Ther 2015;15:165–82.
   PubMed Web of Science ®Google Scholar
• Ma MC, Chen YY, Li SH, et al. Intra-arterial chemotherapy with doxorubicin and cisplatin is effective for advanced hepatocellular cell carcinoma. ScientificWorldJournal 2014;2014:160138.
   PubMedGoogle Scholar
• Qin S, Cheng Y, Liang J, et al. Efficacy and safety of the FOLFOX4 regimen versus doxorubicin in Chinese patients with advanced hepatocellular carcinoma: a subgroup analysis of the EACH study. Oncologist 2014;19:1169–78.
   PubMed Web of Science ®Google Scholar
• Lee SM, O’Halloran TV, Nguyen ST. Polymer-caged nanobins for synergistic cisplatin-doxorubicin combination chemotherapy. J Am Chem Soc 2010;132:17130–8.
   PubMed Web of Science ®Google Scholar
• Li M, Tang Z, Lv S, et al. Cisplatin crosslinked pH-sensitive nanoparticles for efficient delivery of doxorubicin. Biomaterials 2014;35:3851–64.
   PubMed Web of Science ®Google Scholar
• Tomuleasa C, Soritau O, Orza A, et al. Gold nanoparticles conjugated with cisplatin/doxorubicin/capecitabine lower the chemoresistance of hepatocellular carcinoma-derived cancer cells. J Gastrointestin Liver Dis 2012;21:187–96.
   PubMed Web of Science ®Google Scholar
• Macciò A, Madeddu C. Cisplatin : an old drug with a newfound efficacy – from mechanisms of action to cytotoxicity. Expert Opin Pharmacother 2013;14:1839–57.
   PubMed Web of Science ®Google Scholar
• Li X, Takashima M, Yuba E, et al. PEGylated PAMAM dendrimer-doxorubicin conjugate-hybridized gold nanorod for combined photothermal-chemotherapy. Biomaterials 2014;35:6576–84.
   PubMed Web of Science ®Google Scholar
• Wu Y, Lu CT, Li WF, et al. Preparation and antitumor activity of bFGF-mediated active targeting doxorubicin microbubbles. Drug Dev Ind Pharm 2013;39:1712–19.
   PubMed Web of Science ®Google Scholar
• Di Stefano G, Lanza M, Kratz F, et al. A novel method for coupling doxorubicin to lactosaminated human albumin by an acid sensitive hydrazone bond: synthesis, characterization and preliminary biological properties of the conjugate. Eur J Pharm Sci 2004;23:393–7.
   PubMed Web of Science ®Google Scholar
• Wang L, Ren KF, Wang HB, et al. pH-sensitive controlled release of doxorubicin from polyelectrolyte multilayers. Colloids Surf B Biointerfaces 2015;125:127–33.
   PubMed Web of Science ®Google Scholar
• Yoo HS, Park TG. Biodegradable polymeric micelles composed of doxorubicin conjugated PLGA-PEG block copolymer. J Control Release 2001;70:63–70.
   PubMed Web of Science ®Google Scholar
• Dong L, Xia S, Wu K, et al. A pH/enzyme-responsive tumor-specific delivery system for doxorubicin. Biomaterials 2010;31:6309–16.
   PubMed Web of Science ®Google Scholar
• Ogris M, Walker G, Blessing T, et al. Tumor-targeted gene therapy: strategies for the preparation of ligand–polyethylene glycol–polyethylenimine/DNA complexes. J Control Release 2003;91:173–81.
   PubMed Web of Science ®Google Scholar
• Lalani J, Rathi M, Lalan M, Misra A. Protein functionalized tramadol-loaded PLGA nanoparticles: preparation, optimization, stability and pharmacodynamic studies. Drug Dev Ind Pharm 2013;39:854–64.
   PubMed Web of Science ®Google Scholar
• Kobayashi T, Ishida T, Okada Y, et al. Effect of transferrin receptor-targeted liposomal doxorubicin in P-glycoprotein-mediated drug resistant tumor cells. Int J Pharm 2007;329:94–102.
   PubMed Web of Science ®Google Scholar
• Łubgan D, Jóźwiak Z, Grabenbauer GG, et al. Doxorubicin–transferrin conjugate selectively overcomes multidrug resistance in leukaemia cells. Cell Mol Biol Lett 2009;14:113–27.
   PubMed Web of Science ®Google Scholar
• Wang F, Jiang X, Yang DC, et al. Doxorubicin–gallium–transferrin conjugate overcomes multidrug resistance: evidence for drug accumulation in the nucleus of drug resistant MCF-7/ADR cells. Anticancer Res 2000;20:799–808.
   PubMed Web of Science ®Google Scholar
• Fritzer M, Szekeres T, Szüts V, et al. Cytotoxic effects of a doxorubicin–transferrin conjugate in multidrug-resistant KB cells. Biochem Pharmacol 1996;51:489–93.
   PubMed Web of Science ®Google Scholar
• Kulhari H, Pooja D, Singh MK, Chauhan AS. Optimization of carboxylate-terminated poly(amidoamine) dendrimer-mediated cisplatin formulation. Drug Dev Ind Pharm 2015;41:232–8.
   PubMed Web of Science ®Google Scholar
• Oberoi HS, Nukolova NV, Kabanov AV, Bronich TK. Nanocarriers for delivery of platinum anticancer drugs. Adv Drug Deliv Rev 2013;65:1667–85.
   PubMed Web of Science ®Google Scholar
• Kolishetti N, Dhar S, Valencia PM, et al. Engineering of self-assembled nanoparticle platform for precisely controlled combination drug therapy. Proc Natl Acad Sci USA2010;107:17939–44.
   PubMed Web of Science ®Google Scholar
• Kim TH, Jo YG, Jiang HH, et al. PEG-transferrin conjugated TRAIL (TNF-related apoptosis-inducing ligand) for therapeutic tumor targeting. J Control Release 2012;162:422–8.
   PubMed Web of Science ®Google Scholar
• Xu M, Qian J, Suo A, et al. Reduction/pH dual-sensitive PEGylated hyaluronan nanoparticles for targeted doxorubicin delivery. Carbohydr Polym 2013;98:181–8.
   PubMed Web of Science ®Google Scholar
• Dhar S, Daniel WL, Giljohann DA, et al. Polyvalent oligonucleotide gold nanoparticle conjugates as delivery vehicles for platinum(IV) warheads. J Am Chem Soc 2009;131:14652–3.
   PubMed Web of Science ®Google Scholar
• Song H, Wang R, Xiao H, et al. A cross-linked polymeric micellar delivery system for cisplatin(IV) complex. Eur J Pharm Biopharm 2013;83:63–75.
   PubMed Web of Science ®Google Scholar
• Mi Y, Zhao J, Feng SS. Vitamin E TPGS prodrug micelles for hydrophilic drug delivery with neuroprotective effects. Int J Pharm 2012;438:98–106.
   PubMed Web of Science ®Google Scholar
• Zou W, Liu C, Chen Z, Zhang N. Studies on bioadhesive PLGA nanoparticles: a promising gene delivery system for efficient gene therapy to lung cancer. Int J Pharm 2009;370:187–95.
   PubMed Web of Science ®Google Scholar
• Yoo HS, Park TG. Folate-receptor-targeted delivery of doxorubicin nano-aggregates stabilized by doxorubicin–PEG–folate conjugate. J Control Release 2004;100:247–56.
   PubMed Web of Science ®Google Scholar
• Alhareth K, Vauthier C, Gueutin C, et al. HPLC quantification of doxorubicin in plasma and tissues of rats treated with doxorubicin loaded poly(alkylcyanoacrylate) nanoparticles. J Chromatogr B Analyt Technol Biomed Life Sci 2012;887888:128–32.
   Web of Science ®Google Scholar
• Jayant RD, McShane MJ, Srivastava R. Polyelectrolyte-coated alginate microspheres as drug delivery carriers for dexamethasone release. Drug Deliv 2009;16:331–40.
   PubMed Web of Science ®Google Scholar
• Ferrari M, Fornasiero MC, Isetta AM. MTT colorimetric assay for testing macrophage cytotoxic activity in vitro. J Immunol Methods 1990;131:165–72.
   PubMed Web of Science ®Google Scholar
• Chou TC. Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacol Rev 2006;58:621–81.
   PubMed Web of Science ®Google Scholar
• Strobl FG, Seitz F, Westerhausen C, et al. Intake of silica nanoparticles by giant lipid vesicles: influence of particle size and thermodynamic membrane state. Beilstein J Nanotechnol 2014;5:2468–78.
   PubMed Web of Science ®Google Scholar
• Ha HK, Kim JW, Lee MR, et al. Cellular uptake and cytotoxicity of β-lactoglobulin nanoparticles: the effects of particle size and surface charge. Asian-Australas J Anim Sci 2015;28:420–7.
   PubMed Web of Science ®Google Scholar
• Wachsmann P, Lamprecht A. Ethylcellulose nanoparticles with bimodal size distribution as precursors for the production of very small nanoparticles. Drug Dev Ind Pharm 2015;41:1165–71.
   PubMed Web of Science ®Google Scholar
• Cho EC, Xie J, Wurm PA, Xia Y. Understanding the role of surface charges in cellular adsorption versus internalization by selectively removing gold nanoparticles on the cell surface with a I2/KI etchant. Nano Lett 2009;9:1080–4.
   PubMed Web of Science ®Google Scholar
• Liu Z, Zhao H, Shu L, et al. Preparation and evaluation of Baicalin-loaded cationic solid lipid nanoparticles conjugated with OX26 for improved delivery across the BBB. Drug Dev Ind Pharm 2015;41:353–61.
   PubMed Web of Science ®Google Scholar
• Harush-Frenkel O, Rozentur E, Benita S, Altschuler Y. Surface charge of nanoparticles determines their endocytic and transcytotic pathway in polarized MDCK cells. Biomacromolecules 2008;9:435–43.
   PubMed Web of Science ®Google Scholar
• Shalaby KS, Soliman ME, Casettari L, et al. Determination of factors controlling the particle size and entrapment efficiency of noscapine in PEG/PLA nanoparticles using artificial neural networks. Int J Nanomedicine 2014;9:4953–64.
   PubMed Web of Science ®Google Scholar
• Etrych T, Subr V, Laga R, et al. Polymer conjugates of doxorubicin bound through an amide and hydrazone bond: impact of the carrier structure onto synergistic action in the treatment of solid tumours. Eur J Pharm Sci 2014;58:1–12.
   PubMed Web of Science ®Google Scholar
• Zhang CY, Xiong D, Sun Y, et al. Self-assembled micelles based on pH-sensitive PAE-g-MPEG-cholesterol block copolymer for anticancer drug delivery. Int J Nanomedicine 2014;9:4923–33.
   PubMed Web of Science ®Google Scholar
• Feng T, Tian H, Xu C, et al. Synergistic co-delivery of doxorubicin and paclitaxel by porous PLGA microspheres for pulmonary inhalation treatment. Eur J Pharm Biopharm 2014;88:1086–93.
   PubMed Web of Science ®Google Scholar
• Chou TC, Talalay P. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul 1984;22:27–55.
   PubMedGoogle Scholar